Experienced in IgG4-Related Disease

Dr. Brett T. Brinker

Hematology Oncology | Hematology | Oncology
Center For Physical Rehabilitation And Therapy Lp
5060 Cascade Rd Se, Suite A, 
Grand Rapids, MI 
Accepting New Patients

Experienced in IgG4-Related Disease
Center For Physical Rehabilitation And Therapy Lp
5060 Cascade Rd Se, Suite A, 
Grand Rapids, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brett Brinker is a Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Dr. Brinker is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MI
Hospital Affiliations
Spectrum Health
Holland Community Hospital
Spectrum Health United Hospital
Corewell Health Pennock Hospital
Corewell Health Zeeland Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

CENTER FOR PHYSICAL REHABILITATION AND THERAPY LP
5060 Cascade Rd Se, Suite A, Grand Rapids, MI 49546
Call: 616-954-9800
Other Locations
CANCER AND HEMATOLOGY CENTERS OF WESTERN MI, P.C.
145 Michigan St Ne, Suite 3100, Grand Rapids, MI 49503
Call: 616-954-9800
CANCER AND HEMATOLOGY CENTERS OF WESTERN MI, P.C.
710 Kenmoor Ave Se, Suite 200, Grand Rapids, MI 49546
Call: 616-389-1800
CANCER AND HEMATOLOGY CENTERS OF WESTERN MI, P.C.
6425 Harvey St, Norton Shores, MI 49444
Call: 231-737-3469
CANCER AND HEMATOLOGY CENTERS OF WESTERN MI, P.C.
12460 Riley St, Holland, MI 49424
Call: 616-399-6500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: KPT-8602
Study Phase: Phase 1/Phase 2
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drugs: Cedazuridine, Decitabine
Study Phase: Phase 3
Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research
Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research
Enrollment Status: Completed
Publish Date: October 03, 2019
Intervention Type: Other
View 2 Less Clinical Trials

6 Total Publications

Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Journal: The New England journal of medicine
Published: October 16, 2024
View All 6 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. William A. Fabricius
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. William A. Fabricius
Hematology Oncology | Hematology | Oncology

Center For Physical Rehabilitation And Therapy Lp

5060 Cascade Rd Se, Suite A, 
Grand Rapids, MI 
 (0.1 miles away)
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

William Fabricius is a Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Dr. Fabricius is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Inflammatory Breast Cancer. Dr. Fabricius is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Colin A. Hardin
Hematology Oncology | Oncology
Experienced in IgG4-Related Disease
Dr. Colin A. Hardin
Hematology Oncology | Oncology

Cancer And Hematology Centers Of Western Mi, P.C.

710 Kenmoor Ave Se, Suite 200, 
Grand Rapids, MI 
 (1.2 miles away)
616-389-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Colin Hardin is a Hematologist Oncology specialist and an Oncologist in Grand Rapids, Michigan. Dr. Hardin is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Anemia, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Hardin is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brinker's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Brinker is
      Distinguished
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Brinker is
      Distinguished
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Brinker is
      Distinguished
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Brinker is
      Distinguished
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • B-Cell Lymphoma
      Dr. Brinker is
      Distinguished
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Childhood Acute Myeloid Leukemia
      Dr. Brinker is
      Distinguished
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    View All 19 Distinguished Conditions
    • Advanced
    • Acute Hepatic Porphyria (AHP)
      Dr. Brinker is
      Advanced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Acute Intermittent Porphyria
      Dr. Brinker is
      Advanced
      . Learn about Acute Intermittent Porphyria.
      See more Acute Intermittent Porphyria experts
    • Acute Myelomonocytic Leukemia
      Dr. Brinker is
      Advanced
      . Learn about Acute Myelomonocytic Leukemia.
      See more Acute Myelomonocytic Leukemia experts
    • Adult Immune Thrombocytopenia
      Dr. Brinker is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Adult T-Cell Leukemia
      Dr. Brinker is
      Advanced
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • Agranulocytosis
      Dr. Brinker is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    View All 41 Advanced Conditions
    • Experienced
    • Acute Promyelocytic Leukemia
      Dr. Brinker is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adult Soft Tissue Sarcoma
      Dr. Brinker is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Brinker is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Alveolar Soft Part Sarcoma
      Dr. Brinker is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Angiosarcoma
      Dr. Brinker is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Antiphospholipid Syndrome
      Dr. Brinker is
      Experienced
      . Learn about Antiphospholipid Syndrome.
      See more Antiphospholipid Syndrome experts
    View All 140 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved